Here's Why Zydus Wellness Limited's (NSE:ZYDUSWELL) CEO Compensation Is The Least Of Shareholders Concerns
Shareholders may be wondering what CEO Tarun Arora plans to do to improve the less than great performance at Zydus Wellness Limited (NSE:ZYDUSWELL) recently. At the next AGM coming up on 30 July 2021, they can influence managerial decision making through voting on resolutions, including executive remuneration. It has been shown that setting appropriate executive remuneration incentivises the management to act in the interests of shareholders. We think CEO compensation looks appropriate given the data we have put together.
See our latest analysis for Zydus Wellness
How Does Total Compensation For Tarun Arora Compare With Other Companies In The Industry?
According to our data, Zydus Wellness Limited has a market capitalization of ā¹141b, and paid its CEO total annual compensation worth ā¹13m over the year to March 2021. That's a notable increase of 16% on last year. It is worth noting that the CEO compensation consists entirely of the salary, worth ā¹13m.
For comparison, other companies in the same industry with market capitalizations ranging between ā¹74b and ā¹238b had a median total CEO compensation of ā¹32m. In other words, Zydus Wellness pays its CEO lower than the industry median. What's more, Tarun Arora holds ā¹2.2m worth of shares in the company in their own name, indicating that they have a lot of skin in the game.
Component | 2021 | 2020 | Proportion (2021) |
Salary | ā¹13m | ā¹11m | 100% |
Other | - | - | - |
Total Compensation | ā¹13m | ā¹11m | 100% |
Talking in terms of the industry, salary represents all of total compensation among the companies we analyzed, while other remuneration is, interestingly, completely ignored. At the company level, Zydus Wellness pays Tarun Arora solely through a salary, preferring to go down a conventional route. If total compensation veers towards salary, it suggests that the variable portion - which is generally tied to performance, is lower.
A Look at Zydus Wellness Limited's Growth Numbers
Over the last three years, Zydus Wellness Limited has shrunk its earnings per share by 17% per year. It achieved revenue growth of 5.7% over the last year.
Few shareholders would be pleased to read that EPS have declined. And the modest revenue growth over 12 months isn't much comfort against the reduced EPS. It's hard to argue the company is firing on all cylinders, so shareholders might be averse to high CEO remuneration. Moving away from current form for a second, it could be important to check this free visual depiction of what analysts expect for the future.
Has Zydus Wellness Limited Been A Good Investment?
Most shareholders would probably be pleased with Zydus Wellness Limited for providing a total return of 53% over three years. So they may not be at all concerned if the CEO were to be paid more than is normal for companies around the same size.
In Summary...
Zydus Wellness rewards its CEO solely through a salary, ignoring non-salary benefits completely. Despite the strong returns on shareholders' investments, the fact that earnings have failed to grow makes us skeptical about the stock keeping up its current momentum. These concerns could be addressed to the board and shareholders should revisit their investment thesis to see if it still makes sense.
CEO compensation can have a massive impact on performance, but it's just one element. We've identified 2 warning signs for Zydus Wellness that investors should be aware of in a dynamic business environment.
Arguably, business quality is much more important than CEO compensation levels. So check out this free list of interesting companies that have HIGH return on equity and low debt.
If you decide to trade Zydus Wellness, use the lowest-cost* platform that is rated #1 Overall by Barronās, Interactive Brokers. Trade stocks, options, futures, forex, bonds and funds on 135 markets, all from a single integrated account. Promoted
Valuation is complex, but we're here to simplify it.
Discover if Zydus Wellness might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisThis article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
*Interactive Brokers Rated Lowest Cost Broker by StockBrokers.com Annual Online Review 2020
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
About NSEI:ZYDUSWELL
Zydus Wellness
Engages in the development, production, marketing, and distribution of health and wellness products in India.
Flawless balance sheet second-rate dividend payer.